Latest News

Jan 21, 2020

Propanc Biopharma Receives Advance Overseas Finding from Innovation and Science Australia

Propanc to Receive Up to a 43.5% “Cash Back” Benefit from Overseas R&D Expenditure MELBOURNE, Australia--(BUSINESS WIRE)-- Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc” or the “Company”), a…

View All Press Releases